Kodex Synth US Biotech (KRX:185680)

Assets	24.43B
Expense Ratio	0.25%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+62.52%

Volume	2,774
Open	46,440
Previous Close	45,575
Day's Range	46,280 - 46,700
52-Week Low	28,035
52-Week High	55,395
Beta	0.18
Holdings	1
Inception Date	Oct 31, 2013

About 185680

Kodex Synth US Biotech is an exchange traded fund launched and managed by Samsung Asset Management Co. Ltd. The fund invests in public equity markets of the United States. It uses derivatives such as swaps to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It replicates the performance of the S&P Biotechnology Select Industry Index, by using synthetic replication methodology. Kodex Synth US Biotech was formed on October 30, 2013 and is domiciled in South Korea.

• Asset Class: Equity
• Category: Health Care
• Region: North America
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185680
• Provider: KODEX
• Index Tracked: S&P Biotechnology Select Industry

Performance

185680 had a total return of 62.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.96%.

Top Holdings

Name	Symbol	Weight
TRS S&P Biotechnology Select Industry TR USD	n/a	100.00%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error